enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Cerus Corporation - Wikipedia

    en.wikipedia.org/wiki/Cerus_Corporation

    The Intercept Blood System for Platelets received EU CE MARK Class III certification in 2002, and US FDA pre-market approval on December 18, 2014. On March 10, 2016 the FDA granted an expanded modification on the existing approval to also treat platelets suspended in 100% plasma.

  3. Cerus Announces FDA Agreement on Modular Premarket ... - AOL

    www.aol.com/news/2012-12-13-cerus-announces-fda...

    In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma, and is in discussion with FDA to define the additional clinical data required for a regulatory ...

  4. Cerus Signs INTERCEPT Platelet Agreements With Two Key Blood ...

    www.aol.com/news/2013-03-15-cerus-signs...

    In the United States, Cerus is seeking regulatory approval of the INTERCEPT Blood System for plasma, and is in the process of determining the application shell for a potential regulatory ...

  5. Cerus Initiates Patient Enrollment in European Phase III ...

    www.aol.com/news/2013-06-11-cerus-initiates...

    Cerus Initiates Patient Enrollment in European Phase III Clinical Trials for INTERCEPT Red Blood Cells for Acute and Chronic Anemia CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NAS: CERS ...

  6. Innate immune system - Wikipedia

    en.wikipedia.org/wiki/Innate_immune_system

    The innate immune system or nonspecific immune system [1] is one of the two main immunity strategies in vertebrates (the other being the adaptive immune system). The innate immune system is an alternate defense strategy and is the dominant immune system response found in plants , fungi , prokaryotes , and invertebrates (see Beyond vertebrates ).

  7. Pathogen reduction using riboflavin and UV light - Wikipedia

    en.wikipedia.org/wiki/Pathogen_reduction_using...

    Consequently, the development of pathogen inactivation/reduction technologies for blood products has been an ongoing effort in the field of transfusion medicine. A new procedure for the treatment of individual units of single-donor (apheresis) or whole blood–derived, pooled, platelets has recently been introduced.

  8. Swissmedic and Swiss Red Cross Present National ... - AOL

    www.aol.com/news/2013-04-03-swissmedic-and-swiss...

    Swissmedic and Swiss Red Cross Present National Haemovigilance Data Showing Favourable Safety Profile for INTERCEPT-Treated Platelet Components CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation ...

  9. Leukocyte extravasation - Wikipedia

    en.wikipedia.org/wiki/Leukocyte_extravasation

    Neutrophils extravasate from blood vessels to the site of tissue injury or infection during the innate immune response.. In immunology, leukocyte extravasation (also commonly known as leukocyte adhesion cascade or diapedesis – the passage of cells through the intact vessel wall) is the movement of leukocytes (white blood cells) out of the circulatory system (extravasation) and towards the ...